5i Sciences specializes in developing innovative medical products addressing the problem of airway collapse in a large market.
5i Sciences was established for the purpose of developing innovative medical products addressing the problem of airway collapse in a large market - sedation induced airway collapse. It uses the technology known as Continuous Negative External Pressure (cNEPTM). 5i has conducted clinical research demonstrating the safety and efficacy of its products in development. The company's first product is awaiting FDA clearance, and commercial launch is anticipated in the second half of 2014. This product, known as the cNEPTM Airway Management System will address the serious and common problem of airway collapse in sedated patients during medical procedures, resulting in oxygen deprivation
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Jan 1, 2014 | Series Unknown | — | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Keiretsu Forum | — | Series Unknown |